Collection Overview
Scientific Reports has launched a Guest-Edited Collection on Organoid bioprinting from cells to functional tissues.
Organoid bioprinting lies at the intersection of bioprinting, 3D tissues engineering, and biofabrication. Advanced 3D bioprinting technologies now enable precise spatial positioning of cells and guide their maturation into functional organoids. By integrating stem cells and stem-cell–derived organoids with engineered matrices and innovative printing strategies, researchers can replicate complex tissue architectures, model human development and disease, and generate physiologically relevant mini-tissues. This Collection explores the rapidly evolving field of organoid-based biofabrication and its transformative potential for regenerative medicine, drug discovery, and personalised biology.
This will be a Collection of original research papers and will be open for submissions from all authors – on the condition that the manuscripts fall within the scope of the Collection and of Scientific Reports more generally. Narrative review articles are also welcomed to our sister journal, Scientific Reviews. We are welcoming submissions until 9th November 2026.
Why is this Collection important?
"F3D bioprinting merges the top-down spatial control of biofabrication with the bottom-up self-assembly of organoids. By precisely controlling organoid deposition, we can dictate the overall functionality of engineered organ-like structures. Traditional organoids face significant challenges due to a lack of reproducibility and the inability to integrate vascular networks. This Collection aims to bridge bioprinting advancements with organoid research, moving the field toward the creation of integrated and complex tissue structures." - Dr. Bahatin Koc
"Organoid bioprinting lies at the intersection of organoid research, bioprinting, and tissues engineering. Advanced 3D bioprinting technologies now enable precise spatial positioning of cells and guide their maturation into functional organoids. By integrating stem cells and stem-cell–derived organoids with engineered matrices and innovative printing strategies, researchers can replicate complex tissue architectures, model human development and disease, and generate physiologically relevant mini-tissues for therapeutic development. The impact will be manufacturing living tissues on demand. Researchers should submit here to contribute to the effort that bridges biofabrication fundamentals with translational models for drug screening and regenerative medicine." - Dr. Hon Fai Chan
This Collection also supports and amplifies research related to SDG 3 - Good health and wellbeing.
Why submit to a Collection?
Collections like this one help promote high-quality science. They are led by Guest Editors, who are experts in their fields, and In-House Editors and are supported by a dedicated team of Commissioning Editors and Managing Editors at Springer Nature. Collection manuscripts typically see higher citations, downloads, and Altmetric scores, and provide a one-stop-shop on a cutting-edge topic of interest.
Who is involved?
Guest Editors:
- Hon Fai Chan, The Chinese University of Hong Kong, China
- Nileshkumar Dubey, University of Maryland, USA
- Bahattin Koc, Sabanci University, Turkey
Internal Team:
- In-House Editor: Shital Bonde, Scientific Reports, Germany
- Commissioning Editor: Robert Moran, Fully OA Brands, Springer Nature, UK
- Managing Editor: Eleanor Smith, Fully OA Brands, Springer Nature, UK
How can I submit my paper?
Visit the Collection page to find out more about this Collection and how to submit your article.